Apolipoprotein E and Alzheimer's disease. The tip of the susceptibility iceberg

Annals of the New York Academy of Sciences

Volumn 855, Issue , 1998, Pages 738-743

  Roses, Allen D ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ALLELE; ALZHEIMER DISEASE; BRAIN METABOLISM; CHROMOSOME 12; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; GENETIC SUSCEPTIBILITY; HUMAN; LIPOPROTEIN METABOLISM; MOUSE; NONHUMAN; ONSET AGE; TRANSGENIC ANIMAL;

ANIMALIA;

EID: 0032461761     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb10653.x     Document Type: Conference Paper

References (31)

1. 1. Roses, A. D. 1997. A model for susceptibility polymorphisms for complex diseases: apolipoprotein E and Alzheimer disease. Neurogenetics 1: 3-11.
2. 2. Strittmatter, W. J., A. M. Saunders, D. Schmeche, V. M. Pericak, J. Enghild, G. S. Salvesen & A. D. Roses. 1993. Apolipoprotein E: High-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA 90: 1977-1981.
3. 3. Saunders, A. M., W. J. Strittmatter, D. Schmechel, P. H. St. George-Hyslop, M. A. Pericak-Vance, S. H. Joo, B. L. Rosi, J. F. Gusella, D. R. McLaughlin-Crapper, M. J. Alberts, C. Hulette, B. Crain, D. Goldgaber & A. D. Roses. 1993. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43: 1467-1472.
4. 4. Mahley, R. W. 1988. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science 240: 622-630.
5. 5. Roses, A. D. 1996. Apolipoprotein E alleles as risk factors in Alzheimer disease. Annu. Rev. Med. 47: 387-400.
6. 6. Roses, A. D., B. Devlin, P. M. Conneally, G. W. Small, A. M. Saunders, M. Pritchard, P. A. Locke, J. L. Haines, M. A. Pericak-Vance & N. Risch. 1995. Measuring the genetic contribution of APOE in late-onset Alzheimer diease. Amer. J. Hum. Genet. 57: A202.
7. 7. Corder, E. H., A. M. Saunders, W. J. Strittmatter, D. E. Schmechel, P. C. Gaskell, G. W. Small, A. D. Roses, J. L. Haines & M. A. Pericak-Vance. 1993. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921-923.
8. 8. Corder, E. H., A. M. Saunders, N. J. Risch, W. J. Strittmatter, D. E. Schmechel, P. J. Gaskell, J. B. Rimmler, P. A. Locke, P. M. Conneally, K. E. Schmader, G. W. Small, A. D. Roses, J. L. Haines & M. A. Pericak-Vance. 1994. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat. Genet. 7: 180-184.
9. 9. Roses, A. D. 1994. Apolipoprotein E affects the rate of Alzheimer disease expression: beta-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease. J. Neuropathol. Exp. Neurol. 53: 429-437.
10. 10. Elston, R. C. & W. D. Johnson. 1994. Essentials of Biostatistics. F. A. Davis. Philadelphia.
11. 11. McKhann, G., D. Drachman, M. Folstein, R. Katzman, D. Price & E. M. Stadlan. 1984. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34: 939-944.
12. 12. Slooter, A. J., M. M. B. Breteler, A. Ott, C. Van Broeckhoven & C. M. Van Duijn. 1996. APOE genotyping in differential diagnosis of Alzheimer's disease. Lancet 348: 334.
13. 13. Mirra, S. S., M. N. Hart & R. D. Terry. 1993. Making the diagnosis of Alzheimer's disease. A primer for practicing pathologists. Arch. Pathol. Lab. Med. 117: 132-144.
14. 14. Mirra, S. S., A. Heyman, D. McKeel, S. M. Sumi, B. J. Crain, L. M. Brownlee, F. S. Vogel, J. P. Hughes, G. Van Belle & L. Berg. 1991. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41: 479-486.
15. 15. Saunders, A. M., C. Hulette, K. A. Welsh, D. E. Schmechel, B. Crain, J. R. Burke, M. J. Alberts, W. J. Strittmatter, J. C. S. Breitner, C. Rosenberg, S. V. Scott, P. C. J. Gaskell, M. A. Pericak-Vance & A. D. Roses. 1996. Specificity, sensitivity and predictive value of apolipoprotein E genotyping for sporadic Alzheimer disease. Lancet 348: 90-93.
16. 16. Smith, A. D., K. A. Jobst, C. Johnston, C. Joachim & Z. Nagy. 1996. Apolipoprotein-E genotyping in diagnosis of Alzheimer's disease. Lancet 348: 483-484.
17. 17. Kakulas, B. A., S. D. Wilton, V. A. Fabian & T. M. Jones. 1996. Apolipoprotein-E genotyping in the diagnosis of Alzheimer's disease in an autopsy confirmed series. Lancet 348: 483.
18. 18. Welsh-Bohmer, K. A., M. Gearing, A. M. Saunders, A. D. Roses & S. Mirra. 1997. Apolipoprotein E genotypes in a neuropathological series from the Consortium to Establish a Registry for Alzheimer's Disease. Ann. Neurol. 42: 319-325.
19. 19. Roses, A. D. 1995. Perspective: On the metabolism of apolipoprotein E and the Alzheimer diseases. Exp. Neurol. 132: 149-156.
20. 20. Linton, M. F., R. Gish, S. T. Hubl, E. Butler, C. Esquivel, W. I. Bry, J. K. Boyles, M. R. Wardell & S. G. Young. 1991. Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation. J. Clin. Invest. 88: 270-281.
21. 21. Selkoe, D. J. 1994. Alzheimer's disease: A central role for amyloid. J. Neuropathol. Exp. Neurol. 53: 438-447.
22. 22. Namba, Y., M. Tomonaga, H. Kawasaki, E. Otomo & K. Ikeda. 1991. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res 541: 163-166.
23. 23. Schmechel, D. E., M. O. Tiller, P. Tong, M. McSwain, S-H. Han, R. Angel, D. S. Burkhart & M. K. Izard. 1996. Pattern of apolipoprotein E immunoreactivity during brain aging. In Apolipoprotein E and Alzheimer's Disease. A. D. Roses, K. H. Weisgraber & Y. Christen, Eds. : 29-48. Springer-Verlag. Berlin.
24. 24. Han, S. H., C. Hulette, A. M. Saunders, G. Einstein, M. A. Pericak-Vance, W. J. Strittmatter, A. D. Roses & D. E. Schmechel. 1994. Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls. Exp. Neurol. 128: 13-26.
25. 25. Han, S. H., G. Einstein, K. H. Weisgraber, W. J. Strittmatter, A. M. Saunders, M. A. Pericak-Vance, A. D. Roses & D. E. Schmechel. 1994. Apolipoprotein E is localized to the cytoplasm of human cortical neurons: A light and electron microscopic study. J. Neuropathol. Exp. Neurol. 53: 535-544.
26. 26. Benzing, W. C. & E. J. Mufson. 1995. Apolipoprotein E immunoreactivity within neurofibrillary tangles: Relationship to tau and PHF in Alzheimer's disease. Exp. Neurol. 132: 162-171.
27. 27. Xu, P-T, D. Schmechel, T. Rothrock-Christian, D. S. Burkhart, H-L. Qui, B. Popko, P. Sullivan, N. Maeda, A. M. Saunders, A. D. Roses & J. R. Gilbert. 1996. Human apolipoprotein E2, E3 and E4 isoform-specific transgenic mice: Human-like pattern of neuronal immunoreactivity in central nervous system not observed in wild type mice. Neurobiol. Dis. 3: 229-245.
28. 28. Sullivan, P. M., H. Mezdour, Y. Aratari, C. Krouff, J. Najib, R. L. Reddick, S. Quarfordt & N. Maeda. 1997. Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis. J. Biol. Chem. 272(29): 17972-17980.
29. 29. Xu, P. T., J. R. Gilbert, H. L. Qui, T. Rothrockchristian, D. L. Settles, A. D. Roses & D. E. Schmechel. 1998. Regionally specific neuronal expression of human apoE gene in transgenic mice. Neurosci. Lett. 246(2): 65-68.
30. 30. Simonet, W. S., N. Bucay, S. J. Lauer & J. M. Taylor. 1993. A far-downstream hepatocyte-specific control region directs expression of the linked human apolipoprotein E and C-I genes in transgenic mice. J. Biol. Chem. 268: 8221-8229.
31. 31. Mayeux, R., A. M. Saunders, S. Shea, S. Mirra, D. Evans, A. D. Roses, B. T. Crain, M. X. Tang & C. H. Phelps. 1998. Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. N. Engl. J. Med. 338(8): 506-511.